BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Hsieh YP, Huang CH, Lee CY, Chen HL, Lin CY, Chang CC. Hepcidin-25 negatively predicts left ventricular mass index in chronic kidney disease patients. World J Nephrol 2013; 2(2): 38-43 [PMID: 24175264 DOI: 10.5527/wjn.v2.i2.38]
URL: https://www.wjgnet.com/2220-6124/full/v2/i2/38.htm
Number Citing Articles
Driton Vela. Systemic and local hepcidin as emerging and important peptides in renal homeostasis and pathologyBioFactors 2019; 45(2): 118 doi: 10.1002/biof.1468
Rengin Elsurer Afsar, Mehmet Kanbay, Avsin Ibis, Baris Afsar. In-depth review: is hepcidin a marker for the heart and the kidney?Molecular and Cellular Biochemistry 2021; 476(9): 3365 doi: 10.1007/s11010-021-04168-4
Norishi Ueda, Kazuya Takasawa. Impact of Inflammation on Ferritin, Hepcidin and the Management of Iron Deficiency Anemia in Chronic Kidney DiseaseNutrients 2018; 10(9): 1173 doi: 10.3390/nu10091173
Rachel P. L. van Swelm, Jack F. M. Wetzels, Dorine. W. Swinkels. The multifaceted role of iron in renal health and diseaseNature Reviews Nephrology 2020; 16(2): 77 doi: 10.1038/s41581-019-0197-5
Driton Vela. Balance of cardiac and systemic hepcidin and its role in heart physiology and pathologyLaboratory Investigation 2018; 98(3): 315 doi: 10.1038/labinvest.2017.111
Yao-Peng Hsieh, Ching-Hui Huang, Chia-Ying Lee, Ching-Yuang Lin, Chia-Chu Chang. Silencing of hepcidin enforces the apoptosis in iron-induced human cardiomyocytesJournal of Occupational Medicine and Toxicology 2014; 9(1) doi: 10.1186/1745-6673-9-11
Lucia Del Vecchio, Francesco Locatelli. New treatment approaches in chronic kidney disease-associated anaemiaExpert Opinion on Biological Therapy 2014; 14(5): 687 doi: 10.1517/14712598.2014.892577